Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marlene Sophia Kohlhepp"'
Autor:
Hanyang Liu, Guo Yin, Marlene Sophia Kohlhepp, Fabian Schumacher, Jana Hundertmark, Mohamed I. Abdelwahab Hassan, Felix Heymann, Tobias Puengel, Burkhard Kleuser, Alexander Sandy Mosig, Frank Tacke, Adrien Guillot
Publikováno v:
Advanced Science, Vol 11, Iss 30, Pp n/a-n/a (2024)
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) is hallmarked by hepatic steatosis, cell injury, inflammation, and fibrosis. This study elaborates on a multicellular biochip‐based liver sinusoid model to mimic MASLD path
Externí odkaz:
https://doaj.org/article/9272a9bbb3c4464797bd2b110a66e0f0
Autor:
Gizem Günes Günsel, Thomas M. Conlon, Aicha Jeridi, Rinho Kim, Zeynep Ertüz, Niklas J. Lang, Meshal Ansari, Mariia Novikova, Dongsheng Jiang, Maximilian Strunz, Mariia Gaianova, Christine Hollauer, Christina Gabriel, Ilias Angelidis, Sebastian Doll, Jeanine C. Pestoni, Stephanie L. Edelmann, Marlene Sophia Kohlhepp, Adrien Guillot, Kevin Bassler, Hannelore P. Van Eeckhoutte, Özgecan Kayalar, Nur Konyalilar, Tamara Kanashova, Sophie Rodius, Carolina Ballester-López, Carlos M. Genes Robles, Natalia Smirnova, Markus Rehberg, Charu Agarwal, Ioanna Krikki, Benoit Piavaux, Stijn E. Verleden, Bart Vanaudenaerde, Melanie Königshoff, Gunnar Dittmar, Ken R. Bracke, Joachim L. Schultze, Henrik Watz, Oliver Eickelberg, Tobias Stoeger, Gerald Burgstaller, Frank Tacke, Vigo Heissmeyer, Yuval Rinkevich, Hasan Bayram, Herbert B. Schiller, Marcus Conrad, Robert Schneider, Ali Önder Yildirim
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-21 (2022)
Chronic obstructive pulmonary disease is a progressive and incurable chronic condition that involves accumulation of inflammatory macrophages in the lung tissue. Authors here show in mouse models of lung disease that PRMT7, a protein arginine methylt
Externí odkaz:
https://doaj.org/article/a84378847bdf46488a490ed2e06676b9
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Chronic liver diseases from varying etiologies generally lead to liver fibrosis and cirrhosis. Among them, non-alcoholic fatty liver disease (NAFLD) affects roughly one-quarter of the world population, thus representing a major and increasing public
Externí odkaz:
https://doaj.org/article/553d50b3d904423b83c38259ab514faf
Publikováno v:
Methods in Molecular Biology ISBN: 9781071632062
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c614d870ce556d834d547b166634c6f
https://doi.org/10.1007/978-1-0716-3207-9_15
https://doi.org/10.1007/978-1-0716-3207-9_15
Autor:
Jana Knorr, Benedikt Kaufmann, Maria Eugenia Inzaugarat, Theresa Maria Holtmann, Lukas Geisler, Jana Hundertmark, Marlene Sophia Kohlhepp, Laela M. Boosheri, Daisy R. Chilin‐Fuentes, Amanda Birmingham, Kathleen M. Fisch, Joel D. Schilling, Sven H. Loosen, Christian Trautwein, Christoph Roderburg, Münevver Demir, Frank Tacke, Hal M. Hoffman, Ariel E. Feldstein, Alexander Wree
Publikováno v:
Hepatology (Baltimore, Md.)REFERENCES.
Nucleotide-binding oligomerization domain-like receptor-family pyrin domain-containing 3 (NLRP3) inflammasome activation has been shown to result in liver fibrosis. Mechanisms and downstream signaling remain incompletely understood. Here, we studied